Teacher Retirement System of Texas decreased its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 21.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 68,379 shares of the company’s stock after selling 18,820 shares during the quarter. Teacher Retirement System of Texas’ holdings in Ryan Specialty were worth $4,387,000 at the end of the most recent reporting period.
Several other large investors have also recently modified their holdings of RYAN. JPMorgan Chase & Co. boosted its stake in Ryan Specialty by 107.5% during the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after buying an additional 238,064 shares during the period. Bar Harbor Wealth Management boosted its stake in shares of Ryan Specialty by 5.9% during the 4th quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock worth $10,835,000 after purchasing an additional 9,482 shares during the period. Barclays PLC grew its holdings in Ryan Specialty by 1.1% during the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock valued at $108,994,000 after purchasing an additional 17,267 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in Ryan Specialty by 43.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock worth $62,286,000 after purchasing an additional 286,380 shares during the period. Finally, Teachers Retirement System of The State of Kentucky lifted its stake in Ryan Specialty by 51.5% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 30,760 shares of the company’s stock worth $2,042,000 after purchasing an additional 10,460 shares during the last quarter. Institutional investors own 84.82% of the company’s stock.
Ryan Specialty Trading Up 2.0 %
RYAN opened at $72.44 on Tuesday. Ryan Specialty Holdings, Inc. has a 12 month low of $48.48 and a 12 month high of $75.97. The stock has a fifty day moving average price of $68.27 and a 200-day moving average price of $68.07. The firm has a market cap of $18.97 billion, a price-to-earnings ratio of 104.99, a PEG ratio of 1.19 and a beta of 0.71. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.
Ryan Specialty Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were paid a $0.12 dividend. The ex-dividend date was Tuesday, March 4th. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a yield of 0.66%. Ryan Specialty’s dividend payout ratio (DPR) is 69.57%.
Insiders Place Their Bets
In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the business’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $65.99, for a total transaction of $2,309,650.00. Following the transaction, the director now owns 35,609 shares of the company’s stock, valued at $2,349,837.91. This represents a 49.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 241,360 shares of company stock valued at $16,006,428. Insiders own 11.10% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts have recently commented on RYAN shares. Morgan Stanley assumed coverage on Ryan Specialty in a research note on Thursday, December 5th. They set an “overweight” rating and a $90.00 target price on the stock. Wells Fargo & Company lifted their target price on Ryan Specialty from $64.00 to $69.00 and gave the stock an “equal weight” rating in a research report on Friday, February 21st. Royal Bank of Canada cut their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a report on Friday, February 21st. Keefe, Bruyette & Woods lowered their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating for the company in a research report on Friday, February 21st. Finally, UBS Group upped their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the company. According to MarketBeat, Ryan Specialty presently has an average rating of “Hold” and an average price target of $75.27.
Get Our Latest Analysis on RYAN
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles
- Five stocks we like better than Ryan Specialty
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- The 3 Best Retail Stocks to Shop for in August
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- How Can Investors Benefit From After-Hours Trading
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.